{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:46:01Z","timestamp":1775713561030,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T00:00:00Z","timestamp":1334016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00432-012-1215-1","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T13:42:44Z","timestamp":1333978964000},"page":"1369-1377","source":"Crossref","is-referenced-by-count":14,"title":["FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival"],"prefix":"10.1007","volume":"138","author":[{"given":"Stamatios","family":"Theocharis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Giaginis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Sastre-Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,10]]},"reference":[{"key":"1215_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1593\/neo.10328","volume":"12","author":"A Aleshin","year":"2010","unstructured":"Aleshin A, Finn RS (2010) SRC: a century of science brought to the clinic. Neoplasia 12:599\u2013607","journal-title":"Neoplasia"},{"key":"1215_CR2","volume-title":"World Health Organization classifications tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichert P, Sidransky D (2005) World Health Organization classifications tumours. Lyon, IARC Press, Pathology and genetics of head and neck tumours"},{"key":"1215_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00432-009-0633-1","volume":"136","author":"O Ben-Izhak","year":"2010","unstructured":"Ben-Izhak O, Cohen-Kaplan V, Nagler RM (2010) The prognostic role of phospho-Src family kinase analysis in tongue cancer. J Cancer Res Clin Oncol 136:27\u201334","journal-title":"J Cancer Res Clin Oncol"},{"key":"1215_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","volume":"29","author":"M Brandwein-Gensler","year":"2005","unstructured":"Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167\u2013178","journal-title":"Am J Surg Pathol"},{"key":"1215_CR5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360:1131\u20131135","journal-title":"Lancet"},{"key":"1215_CR6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1368-8375(01)00109-9","volume":"38","author":"MT Canto","year":"2002","unstructured":"Canto MT, Devesa SS (2002) Oral cavity and pharynx cancer incidence in the United States, 1975\u20131988. Oral Oncol 38:610\u2013617","journal-title":"Oral Oncol"},{"key":"1215_CR7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/138955708785740634","volume":"8","author":"X Cao","year":"2008","unstructured":"Cao X, You QD, Li ZY et al (2008) Recent progress of SRC family kinase inhibitors as anticancer agents. Mini Rev Med Chem 8:1053\u20131063","journal-title":"Mini Rev Med Chem"},{"key":"1215_CR8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1517\/14728222.11.10.1315","volume":"11","author":"NA Chatzizacharias","year":"2007","unstructured":"Chatzizacharias NA, Kouraklis GP, Theocharis SE (2007) Focal adhesion kinase: a promising target for anticancer therapy. Expert Opin Ther Targets 11:1315\u20131328","journal-title":"Expert Opin Ther Targets"},{"key":"1215_CR9","first-page":"629","volume":"23","author":"NA Chatzizacharias","year":"2008","unstructured":"Chatzizacharias NA, Kouraklis GP, Theocharis SE (2008) Clinical significance of FAK expression in human neoplasia. Histol Histopathol 23:629\u2013650","journal-title":"Histol Histopathol"},{"key":"1215_CR10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MPA.0b013e3181d7abcc","volume":"39","author":"NA Chatzizacharias","year":"2010","unstructured":"Chatzizacharias NA, Giaginis C, Zizi-Serbetzoglou D et al (2010) Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma. Pancreas 39:930\u2013936","journal-title":"Pancreas"},{"key":"1215_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12253-010-9310-6","volume":"17","author":"NA Chatzizacharias","year":"2011","unstructured":"Chatzizacharias NA, Giaginis C, Gatzidou E et al (2011) Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma. Pathol Oncol Res 17:277\u2013285","journal-title":"Pathol Oncol Res"},{"key":"1215_CR12","unstructured":"Chatzizacharias NA, Kouraklis GP, Giaginis CT et al. (2012) Clinical significance of Src expression and activity in human neoplasia. Histol Histopathol (in press)"},{"key":"1215_CR13","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1021\/jf1049408","volume":"59","author":"PN Chen","year":"2011","unstructured":"Chen PN, Chu SC, Kuo WH et al (2011) Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. J Agric Food Chem 59:3836\u20133844","journal-title":"J Agric Food Chem"},{"key":"1215_CR14","doi-asserted-by":"crossref","unstructured":"Cheng SJ, Kok SH, Lee JJ et al. (2011) Significant association of SRC protein expression with the progression, recurrence, and prognosis of oral squamous cell carcinoma in Taiwan. Head Neck (in press)","DOI":"10.1002\/hed.21923"},{"key":"1215_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jcb.20956","volume":"99","author":"BD Cox","year":"2006","unstructured":"Cox BD, Natarajan M, Stettner MR et al (2006) New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99:35\u201352","journal-title":"J Cell Biochem"},{"key":"1215_CR16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1158\/1078-0432.CCR-1183-3","volume":"10","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, Ito H, Zinner MJ et al (2004) Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res 10:2307\u20132318","journal-title":"Clin Cancer Res"},{"key":"1215_CR17","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1158\/1078-0432.CCR-11-0288","volume":"17","author":"RS Finn","year":"2011","unstructured":"Finn RS, Bengala C, Ibrahim N, Roch\u00e9 H, Sparano J, Strauss LC, Fairchild J, Sy O, Goldstein LJ (2011) Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study. Clin Cancer Res 17:6905\u20136913","journal-title":"Clin Cancer Res"},{"key":"1215_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/187152010794728648","volume":"10","author":"VM Golubovskaya","year":"2010","unstructured":"Golubovskaya VM (2010) Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem 10:735\u2013741","journal-title":"Anticancer Agents Med Chem"},{"key":"1215_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canlet.2009.01.033","volume":"279","author":"YT Ho","year":"2009","unstructured":"Ho YT, Yang JS, Li TC et al (2009) Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 279:155\u2013162","journal-title":"Cancer Lett"},{"key":"1215_CR20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/377539a0","volume":"377","author":"D Ilic","year":"1995","unstructured":"Ilic D, Furuta Y, Kanazawa S et al (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539\u2013544","journal-title":"Nature"},{"key":"1215_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/msy.2003.224","volume":"134","author":"H Ito","year":"2003","unstructured":"Ito H, Gardner-Thorpe J, Zinner MJ et al (2003) Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 134:221\u2013226","journal-title":"Surgery"},{"key":"1215_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"1215_CR23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00432-010-0780-4","volume":"136","author":"H Jiang","year":"2010","unstructured":"Jiang H, Liu L, Ye J, Liu H, Xing S, Wu Y (2010) Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer. J Cancer Res Clin Oncol 136:1295\u20131302","journal-title":"J Cancer Res Clin Oncol"},{"key":"1215_CR24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1054\/bjoc.2000.1323","volume":"83","author":"S Kantola","year":"2000","unstructured":"Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho O-P, Salo T (2000) Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 83:614\u2013619","journal-title":"Br J Cancer"},{"key":"1215_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2011.03.006","volume":"306","author":"SA Kim","year":"2011","unstructured":"Kim SA, Kwon SM, Kim JA et al (2011) 5\u2032-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin \u03b21\/FAK\/Akt signaling. Cancer Lett 306:197\u2013204","journal-title":"Cancer Lett"},{"key":"1215_CR26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1097-0142(19950401)75:7<1649::AID-CNCR2820750715>3.0.CO;2-E","volume":"75","author":"J Klijanienko","year":"1995","unstructured":"Klijanienko J, el-Naggar AK, de Braud F et al (1995) Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75:1649\u20131656","journal-title":"Cancer"},{"key":"1215_CR27","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-07-1902","volume":"13","author":"S Kopetz","year":"2007","unstructured":"Kopetz S, Shah AN, Gallick GE (2007) Src continues aging: current and future clinical directions. Clin Cancer Res 13:7232\u20137236","journal-title":"Clin Cancer Res"},{"key":"1215_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/13543784.12.1.51","volume":"12","author":"AD Laird","year":"2003","unstructured":"Laird AD, Cherrington JM (2003) Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents. Expert Opin Investig Drugs 12:51\u201364","journal-title":"Expert Opin Investig Drugs"},{"key":"1215_CR29","doi-asserted-by":"crossref","first-page":"30455","DOI":"10.1074\/jbc.272.48.30455","volume":"272","author":"S Li","year":"1997","unstructured":"Li S, Kim M, Hu YL et al (1997) Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases. J Biol Chem 272:30455\u201330462","journal-title":"J Biol Chem"},{"key":"1215_CR30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1083\/jcb.119.4.905","volume":"119","author":"L Lipfert","year":"1992","unstructured":"Lipfert L, Haimovich B, Schaller MD et al (1992) Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 119:905\u2013912","journal-title":"J Cell Biol"},{"key":"1215_CR31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12253-010-9269-3","volume":"16","author":"C Michailidi","year":"2010","unstructured":"Michailidi C, Giaginis C, Stolakis V et al (2010) Evaluation of FAK and Src expression in human benign and malignant thyroid lesions. Pathol Oncol Res 16:97\u2013107","journal-title":"Pathol Oncol Res"},{"key":"1215_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1445-2197.2008.04791.x","volume":"79","author":"RS Patel","year":"2009","unstructured":"Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O\u2019Brien CJ (2009) Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg 79:19\u201322","journal-title":"ANZ J Surg"},{"key":"1215_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9610(00)00433-5","volume":"180","author":"A Po Wing Yen","year":"2000","unstructured":"Po Wing Yen A, Lam KY, Wei WI et al (2000) A comparison of prognostic significance of tumor diameter, length, width, thickness area, volume and clinicopathological features of oral tongue carcinoma. Am J Surg 180:139\u2013143","journal-title":"Am J Surg"},{"key":"1215_CR34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.10094","volume":"24","author":"A Po Wing Yen","year":"2002","unstructured":"Po Wing Yen A, Lam KY, Lam LK et al (2002) Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features. Head Neck 24:513\u2013520","journal-title":"Head Neck"},{"key":"1215_CR35","doi-asserted-by":"crossref","first-page":"33714","DOI":"10.1074\/jbc.273.50.33714","volume":"273","author":"N Rahimi","year":"1998","unstructured":"Rahimi N, Hung W, Tremblay E et al (1998) c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells. J Biol Chem 273:33714\u201333721","journal-title":"J Biol Chem"},{"key":"1215_CR36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26:645\u2013662","journal-title":"Cancer Metastasis Rev"},{"key":"1215_CR37","doi-asserted-by":"crossref","unstructured":"Sen B, Peng SH, Woods DM et al. (2011) STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. Clin Cancer Res (in press)","DOI":"10.1007\/978-3-642-10858-7"},{"key":"1215_CR38","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20\u201344\u00a0years. Cancer 103:1843\u20131849","journal-title":"Cancer"},{"key":"1215_CR39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000227604","volume":"54","author":"S Shintani","year":"1997","unstructured":"Shintani S, Matsura H, Hasegawa Y, Nakayama B, Fujimoto Y (1997) The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology 54:463\u2013467","journal-title":"Oncology"},{"key":"1215_CR40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI116200","volume":"91","author":"MS Talamonti","year":"1993","unstructured":"Talamonti MS, Roh MS, Curley SA et al (1993) Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 91:53\u201360","journal-title":"J Clin Invest"},{"key":"1215_CR41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0714.2010.00945.x","volume":"40","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C et al (2011) Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Med Pathol 40:218\u2013226","journal-title":"J Oral Med Pathol"},{"key":"1215_CR42","doi-asserted-by":"crossref","unstructured":"Trarbach T, Schultheis B, Gauler TC et al. (2011) Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours. Invest New Drugs (in press)","DOI":"10.1007\/s10637-011-9754-x"},{"key":"1215_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N","volume":"180","author":"BS Verbeek","year":"1996","unstructured":"Verbeek BS, Vroom TM, Adriaansen-Slot SS et al (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180:383\u2013388","journal-title":"J Pathol"},{"key":"1215_CR44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjc.6604633","volume":"99","author":"D Wangsa","year":"2008","unstructured":"Wangsa D, Ryott M, Avall-Lundquist E et al (2008) Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 99:1121\u20131128","journal-title":"Br J Cancer"},{"key":"1215_CR45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1600-0714.2008.00728.x","volume":"38","author":"J Xia","year":"2009","unstructured":"Xia J, Lv N, Hong Y et al (2009) Increased expression of focal adhesion kinase correlates with cellular proliferation and apoptosis during 4-nitroquinoline-l-oxide-induced rat tongue carcinogenesis. J Oral Pathol Med 38:524\u2013529","journal-title":"J Oral Pathol Med"},{"key":"1215_CR46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1091\/mbc.5.4.413","volume":"5","author":"Z Xing","year":"1994","unstructured":"Xing Z, Chen HC, Nowlen JK et al (1994) Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol Biol Cell 5:413\u2013421","journal-title":"Mol Biol Cell"},{"key":"1215_CR47","doi-asserted-by":"crossref","first-page":"30597","DOI":"10.1074\/jbc.M910027199","volume":"275","author":"LH Xu","year":"2000","unstructured":"Xu LH, Yang X, Bradham CA et al (2000) The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem 275:30597\u201330604","journal-title":"J Biol Chem"},{"key":"1215_CR48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1357-2725(97)00008-3","volume":"29","author":"I Zachary","year":"1997","unstructured":"Zachary I (1997) Focal adhesion kinase. Int J Biochem Cell Biol 29:929\u2013934","journal-title":"Int J Biochem Cell Biol"},{"key":"1215_CR49","doi-asserted-by":"crossref","first-page":"19031","DOI":"10.1016\/S0021-9258(18)41733-4","volume":"267","author":"I Zachary","year":"1992","unstructured":"Zachary I, Sinnett-Smith J, Rozengurt E (1992) Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate. J Biol Chem 267:19031\u201319034","journal-title":"J Biol Chem"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-012-1215-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1215-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T13:51:32Z","timestamp":1641995492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-012-1215-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,10]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1007\/s00432-012-1215-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,10]]}}}